Leerink Partners is a Boston-based healthcare investment bank and capital markets firm that works with life sciences companies on financings and has direct co-investment relevance in later-stage biotech and drug-development rounds. The firm is most relevant for U.S. biotechnology, pharmaceuticals, life sciences, HealthTech and medical devices companies seeking healthcare capital markets relationships or investment-bank-affiliated capital around later-stage financings.